前收市價 | 21.84 |
開市 | 21.87 |
買盤 | 21.74 x 無 |
賣出價 | 22.28 x 無 |
今日波幅 | 21.85 - 21.87 |
52 週波幅 | 16.84 - 22.25 |
成交量 | |
平均成交量 | 0 |
市值 | 無 |
Beta 值 (5 年,每月) | 無 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | 無 |
業績公佈日 | 2024年8月07日 - 2024年8月12日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 無 |
For years, Japan's Fujifilm pivoted away from its legacy camera business to focus on healthcare. Fujifilm is struggling to meet demand for the $1,599 camera, prized by young 20-something social media fans for its looks and high-end functions. After it sold out last year, the company increased production in China to double the launch volume for the VI that debuted in March, said Yujiro Igarashi, manager of Fujifilm's professional imaging group.
FUJIFILM's (FUJIY) fiscal fourth-quarter performance is driven by healthy revenue growth in the Business Innovation, Materials and Consumer Imaging segment.
FUJIFILM's (FUJIY) fiscal third-quarter performance benefits from solid revenue growth in Medical Systems, Business Solutions and Consumer Imaging.